Oxidation of hemoglobin and redistribution of band 3 promote erythrophagocytosis in visceral leishmaniasis.
In visceral leishmaniasis (VL), oxidative assault on erythrocytes perturbs their cellular environment and makes them vulnerable to premature hemolysis. In this study, we assessed the contribution of oxidation-induced modifications of hemoglobin and membrane protein band 3 in the reduced survival of red cells in VL. Oxidative transformation of oxyhemoglobin to hemichrome enhanced its interaction with erythrocyte membrane in the infected animals. Association between denatured globin and band 3 contributed to the formation of insoluble copolymer of macromolecular dimension. Disulfide bonding appeared to be necessary in the making of high molecular weight aggregates during copolymerization. Hemichrome induced clustering of band 3 promoted generation of epitopes on erythrocyte cell surface. This provided a signal favoring immunologic recognition of redistributed band 3 by autologous IgG followed by erythrophagocytosis. An eventual outcome of the sequence of events pointed to early removal of affected red cells from circulation during the disease.
Saha Roy
Sudipa
S
Department of Physiology, Indian Institute of Chemical Biology, CSIR, Kolkata, India.
Chowdhury
Kaustav Dutta
KD
Sen
Gargi
G
Biswas
Tuli
T
D000818:Animals; D001457:Anion Exchange Protein 1, Erythrocyte / Q000378:metabolism*; D006224:Cricetinae; D003412:Cricetulus; D004910:Erythrocyte Membrane / Q000378:metabolism; D004912:Erythrocytes / Q000166:cytology / Q000378:metabolism*; D006420:Hemeproteins / Q000378:metabolism; D006454:Hemoglobins / Q000378:metabolism*; D006461:Hemolysis / Q000502:physiology*; D007898:Leishmaniasis, Visceral / Q000378:metabolism*; D008264:Macrophages / Q000378:metabolism; D010084:Oxidation-Reduction; D010587:Phagocytosis / Q000502:physiology*
D001457:Anion Exchange Protein 1, Erythrocyte; D006420:Hemeproteins; D006454:Hemoglobins; C001332:hemichrome
J Biol Chem. 1989 Apr 15;264(11):6438-46
2649501
Br J Haematol. 1972 Mar;22(3):319-29
4552217
Toxicol Sci. 2004 Dec;82(2):647-55
15456924
Blood. 2000 Nov 1;96(9):2925-33
11049968
Biochemistry. 1985 Jan 1;24(1):34-9
3994972
Biochemistry. 1987 Mar 24;26(6):1777-83
3593688
Arch Biochem Biophys. 2005 Apr 1;436(1):121-7
15752716
Proc Natl Acad Sci U S A. 1986 May;83(10):3311-5
3458184
Blood. 1995 Sep 1;86(5):2014-20
7655029
J Lipid Res. 1965 Jul;6:428-31
14336214
Trans R Soc Trop Med Hyg. 1967;61(5):701-5
6055561
Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
388439
Free Radic Biol Med. 2005 May 1;38(9):1257-64
15808423
J Biol Chem. 1951 Nov;193(1):265-75
14907713
Blood. 1997 Feb 15;89(4):1121-32
9028933
J Clin Invest. 1986 Nov;78(5):1155-60
2945831
J Biol Chem. 1960 Mar;235:769-75
13793161
Ann Hematol. 2001 Jan;80(1):32-7
11233773
Nature. 1970 Aug 15;227(5259):680-5
5432063
Arch Dermatol. 1984 Dec;120(12):1582-4
6508329
J Clin Invest. 1974 Sep;54(3):678-89
4854449
Blood. 1955 Jun;10(6):646-9
14378284
Mol Cell Biochem. 1995 May 24;146(2):99-105
7565650
J Biol Chem. 1988 Sep 25;263(27):13766-73
2971044
Biochim Biophys Acta. 1975 Jun 26;393(2):404-18
167836
Biochem J. 1964 Feb;90(2):374-8
4284220
Blood. 1984 Sep;64(3):733-41
6466875
Free Radic Res. 2004 May;38(5):527-34
15293561
Mol Biochem Parasitol. 2005 Jul;142(1):98-105
15907563
J Biol Chem. 1972 Nov 10;247(21):6960-2
4673289
J Biol Chem. 1991 Dec 15;266(35):23611-7
1748639
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2402-7
15701694
Blood. 1948 Mar;3(3):249-75
18902574
J Biol Chem. 1984 Aug 25;259(16):10238-46
6469962
Blood. 1993 Jun 1;81(11):3146-52
8499648
Blood. 1987 Feb;69(2):401-7
3542079
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7368-72
3313392
Arch Biochem Biophys. 1963 Jan;100:119-30
14028302
Mol Biochem Parasitol. 1983 Sep;9(1):15-28
6199667
Methods Enzymol. 1972;25:457-64
23014426
Science. 1985 Feb 1;227(4686):531-3
2578228